CSRMY Stock UPDATES Consort Med Plc ADR (CSRMY) 15.4700 08/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Consort Med Plc ADR (CSRMY) 15.4700 $CSRMY

The European Injectable Drug Delivery Technologies Expected to Reach $12.4 Billion by 2017 at a CAGR of 12.7% from 2012 To 2017
M2 - Wed Feb 26, 7:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/37kjcm/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" report to their offering. This research report categorizes the European injectable drug delivery technologies market into two segments, namely, Europe injectable drug delivery devices technologies and European injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (Germany, France, U.K., Spain, Italy, Russia and Rest of Europe (RoE)) to provide in-depth information on the European scenario. The European injectable drug delivery technologies market was valued at $6.8 billion in 2012, and is expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017. Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and the development of nanotechnologies. In addition, the market is segmented on the basis of its therapeutic applications. In the therapeutic field, hormonal disorders command the major segment due to the high demand of injectable in the treatment of diabetes. The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as Spain, Russia, Denmark, Ireland and others. However, factors such as needle-stick injuries and infections and development of alternate delivery methods are restraining the growth of the market. Companies Mentioned: - Alkermes, Inc - Bespak Europe, Ltd (Subsidiary Of Consort Medical, Plc) - Crossject - Gerresheimer AG - Haselmeier Gmbh - Injex Pharma Gmbh (Subsidiary Of Hns International, Inc) - Novo Nordisk A/S - Owen Mumford, Ltd - Sanofi - Schott AG - Vetter Pharma-Fertigung Gmbh & Co KG - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/37kjcm/european About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Global And US Pharmaceutical Packaging Market For Manufacturing And Contract Packaging - 2013 Report
M2 - Mon Sep 16, 5:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6cdhl8/global_and_u_s) has announced the addition of the "Global And U.S. Pharmaceutical Packaging Market For Manufacturing And Contract Packaging - Industry Analysis, Size, Share, Growth, Trends & Forecast, 2012 - 2018" report to their offering. Development of new packaging solutions which provide product protection, quality, patient comfort and compliance, and security needs are expected to increase consumer consumption. This in turn is expected to drive the market for novel pharmaceutical packaging. In addition, increasing global drug counterfeit market and the subsequent development of anti-counterfeiting drug packaging technologies and products is expected to boost the demand for pharmaceutical packaging over the next few years. Furthermore, introduction and implementation of numerous stringent regulations and standards for pharmaceutical packaging by regulatory bodies such as Healthcare Compliance Packaging Council (HCPC), National Quality Forum (NQF) and Food and Drug Administration (FDA) is expected to fuel the growth of the market within the forecast period. However, availability of raw materials and volatility in the price of raw materials is expected to hamper the growth of the market. Moreover, complicated registration procedure of packaging is expected to be a key challenge in the growth of the market. North America dominated the pharmaceutical packaging market and accounted for over 30% of the market in 2011. The dominance of the North American region in the packaging market is primarily due to the large demand of pharmaceutical packaging in the U.S. and Canada. However, Asia Pacific is expected to show the fastest growth within the forecast period due to increased contract manufacturing activities, ageing population and growth of medical industry. Asia Pacific is expected to account for over 25% of the market by 2018. The pharmaceutical packaging market was highly fragmented in nature with the top five companies accounting for less than 25% of the market in 2011. Amcor, Becton Dickinson, Gerresheimer AG, MeadWestvaco and Rexam PLC were some of the leading manufacturers present in the market. Amcor was the largest company leading the pharmaceutical packaging market in 2011. Some other prominent manufacturers present in the market include West Pharmaceutical Services, Tear and Tape, 3M, Nypro, Schott, Consort Medical and Ypsomed. Key Topics Covered: 1 Preface 2 Executive Summary 3 Pharmaceutical Packaging : Industry Analysis 3.1 Introduction 3.2 Value chain analysis 3.3 Market drivers 3.4 Market restraints 3.5 Market opportunity 3.6 Porters five forces analysis 3.7 Pharmaceutical packaging market: Company market share analysis 3.8 Pharmaceutical packaging: Market attractiveness analysis 4 Pharmaceutical Packaging Market: Product Segment Analysis 4.1 Pharmaceutical packaging market: Product overview 4.2 Pharmaceutical packaging market, by product segment 5 Pharmaceutical Packaging Market: Regional Analysis 5.1 Pharmaceutical packaging market: Regional overview 5.2 North America 5.3 Europe 5.4 Asia Pacific 5.5 Rest of the World (RoW) 6 Company Profiles Companies Mentioned - Amcor - Catalent Pharma Solutions - Gerresheimer - MeadWestvaco - Rexam - Schott - West Pharmaceutical Services For more information visit http://www.researchandmarkets.com/research/6c...al_and_u_s About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

European Injectable Drug Delivery Market Report 2013-2017
M2 - Fri Sep 13, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sgx9cg/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" report to their offering. Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and development of nanotechnologies. Based on product type, the injectable drug delivery devices technologies market is further categorized as conventional injection devices, self-injection devices, and others (microneedles, nanoneedles and blunt needle injections), while the injectable drug delivery formulation technologies market is categorized as conventional drug delivery formulations and novel drug delivery formulations. The conventional injection devices segment accounted for the largest share of the European injectable drug delivery technologies market in 2012. The market is also segmented on the basis of its therapeutic applications as auto immune diseases, hormonal imbalances, oncology, orphan/rare diseases (Hemophilia, Ribose-5-phosphate isomerase deficiency (RPI deficiency), Cystic Fibrosis, and Wilsons disease) and others (pain management, allergies, hepatitis C, and aesthetic treatment). Hormonal disorders commanded the largest share of the European injectable drug delivery technologies market in 2012. The European injectable drug delivery technologies market has witnessed challenging and dynamic market conditions (due to technological advancements and surge of biologics and biosimilars in pharmaceutical market) over the last five years. Newer products with better safety and efficacy contribute to the widespread adoption of injectable drug delivery technologiesby physicians and patients. However, factors such as needle-stick injuries and infections and development of alternate delivery methods (oral, nasal and topical) for injectable drugs are restraining the growth of the market. The key players in this market are Becton Dickinson & Co. (U.S.), Baxter International, Inc. (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Eli Lily & Co. (U.S.), Gerresheimer AG (Germany), Sanofi (France), West Pharmaceutical Services, Inc. (U.S.), Haselmeier GmbH (Germany), and Owen Mumford, Ltd. (U.K.). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 European Injectable Drug Delivery Devices Technologies Market 5 European Injectable Drug Delivery Formulation Technologies Market 6 European Injectable Drug Delivery Technologies Market, By Therapeutic Applications 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Overview, Financials, Products & Services, Strategy, & Developments - Alkermes, Inc - Bespak Europe, Ltd (Subsidiary Of Consort Medical, Plc) - Crossject - Gerresheimer AG - Haselmeier Gmbh - Injex Pharma Gmbh (Subsidiary Of Hns International, Inc) - Novo Nordisk A/S - Owen Mumford, Ltd - Sanofi - Schott AG - Vetter Pharma-Fertigung Gmbh & Co KG - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/sgx9cg/european

Injectable Drug Delivery 2013 Report
M2 - Thu Aug 29, 3:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rnpgd5/injectable_drug) has announced the addition of the Injectable Drug Delivery 2013 Report to their offering. Global Injectable Drug Delivery Technologies Market Forecast To Reach $43.3 Billion By 2017 At A CAGR Of 14.0% From 2012 To 2017 This research report categorizes the global injectable drug delivery technologies market into two segments:global injectable drug delivery devices technologies and global injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography to provide in-depth information on the global scenario. Market Highlights Growth drivers for the injectable drug delivery technologies market include product life cycle management, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes at global level and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as, India, and China. However, factors such as needle-stick injuries and infections, development of alternate delivery methods and product recalls are restraining the growth of the market. North America accounted for the largest market share of 41.3% of the global injectable drug delivery technologies market, followed by Europe (30.2%) in 2012. However, the region lags behind Europe in the self injection devices market. This is owing to low penetration rate of pen injectors in the US Asian and Latin American countries represent the fastest growing markets due to growing number of cancer and diabetes incidences, and improving patent compliance. Furthermore, stringent regulatory policies for approval of medical devices, and high competition in mature countries will compel the companies to focus on the emerging markets in Latin America and Asia. Key Topics Covered 1 Introduction 2 Executive Summary 3 Market Overview 3.1 Introduction 3.2 Market Segmentation 3.3 Market Dynamics 3.4 Market Share Analysis, By Major Players 4 Global Injectable Drug Delivery Devices Technologies Market 4.1 Introduction 4.2 Market Segmentation 4.3 Manufacturers Criteria For Selection Of An Injectable Device 4.4 Conventional Injectable Drug Delvery Devices 4.5 Self-Injection Devices 4.6 Others 5 Global Injectable Drug Delivery Formulation Technologies Market 5.1 Introduction 5.2 Conventional Drug Delivery 5.3 Novel Drug Delivery Formulation Technologies 6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications 6.1 Introduction 6.2 Auto-Immune Diseases 6.3 Hormonal Disorders 6.4 Orphan/Rare Diseases 6.5 Oncology 6.6 Others 7 Geographic Analysis 8 Competitive Landscape 8.1 Introduction 8.2 Expansion 8.3 Agreements, Partnerships, Collaborations & Joint Ventures 8.4 New Product Launch 8.5 Mergers & Acquisitions 8.6 Other Developments 8.7 Approvals 9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* Companies Mentioned - Alkermes - Antares Pharma - Baxter International - Becton, Dickinson And Company - Bespak Europe, Ltd. (Subsidiary Of Consort Medical, Plc) - Crossject - Elcam Medical - Eli Lilly And Company - Gerresheimer - Haselmeier - Injex Pharma (Subsidiary Of Hns International) - Novo Nordisk - Owen Mumford - Sanofi - Schott - Shl Group - Terumo Corporation - Unilife Corporation - Vetter Pharma-Fertigung - West Pharmaceutical Services - Ypsomed Holding - Zogenix For more information visit http://www.researchandmarkets.com/research/rn...table_drug About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

European Injectable Drug Delivery Report 2013: Market Forecasts to 2017
M2 - Mon Jul 08, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9dn3fj/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" report to their offering. European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017 This research report categorizes the European injectable drug delivery technologies market into two segments, namely, Europe injectable drug delivery devices technologies and European injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (Germany, France, U.K., Spain, Italy, Russia and Rest of Europe (RoE)) to provide in-depth information on the European scenario. The

Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Fri Apr 12, 11:06AM CDT
Research and Markets has announced the addition of the "Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global

Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Wed Mar 27, 4:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v5s9t8/ireland_drug) has announced the addition of the "Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. Scope - Market size and company share data for Drug Delivery Devices market cate

Israel Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Tue Mar 19, 6:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lrkmsk/israel_drug) has announced the addition of the "Israel Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" report to their offering. This new report, Israel Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Israel Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline

Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Tue Mar 12, 11:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qq78sw/canada_drug) has announced the addition of GlobalData's new report "Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Canada Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials

South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 9:21AM CST
Research and Markets (http://www.researchandmarkets.com/research/x55r9s/south_africa_drug) has announced the addition of GlobalData's new report "South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the South Africa Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with informatio

Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 6:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/9k86t3/middle_east_and) has announced the addition of GlobalData's new report "Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Middle East and Africa Drug Delivery Devices market - South Africa, Saudi Arabia and Israel. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report

Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 6:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/8flr2d/asiapacific_drug) has announced the addition of GlobalData's new report "Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report provides key market data on the Asia Pacific Drug Delivery Devices market - Japan, China, India, and Australia. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - 2011 compa

United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 8:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/ggj4tv/united_kingdom) has announced the addition of GlobalData's new report "United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the United Kingdom Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with informat

Mexico Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 7:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/fkjq86/mexico_drug) has announced the addition of GlobalData's new report "Mexico Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, Mexico Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Mexico Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials a

South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 6:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/7gl7rn/south_and_central) has announced the addition of GlobalData's new report "South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the South and Central America Drug Delivery Devices market - Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. Scope - Cou

North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 6:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/bhd7b3/north_america) has announced the addition of GlobalData's new report "North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the North America Drug Delivery Devices market - United States and Canada. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geothermal AI Nodes Take Aim at Stranded Well Power

Updated Category News Views 48

Millions of idle wells are sitting under America like unwanted basement clutter, and GEIOS GEOFLEX thinks some can become small, self-contained AI power plants. That is the provocative idea behind its Dark Token Factory partnership with Aiden Digital Labs: bolt an autonomous compute module onto an abandoned or non-producing oil and gas well, pull geothermal heat from...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 150

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
JOYY Q3 Growth Shows More Than Livestreaming Muscle

Updated Category News Views 59

Revenue finally has more than one pair of legs at JOYY, and that matters a whole lot more than a flashy quarterly headline. The company reported third-quarter 2026 revenue of US$624.6 million, up 15.6% from a year earlier and 5.7% from the prior quarter. Those are not microscopic moves, and the composition is the part that deserves the hard stare. JOYY is still rooted in...

Continue Reading
COSCO Shipping Uses CIIE to Put People in the Chain

Updated Category News Views 57

A Supply Chain Is Not Just Steel and Schedules Containers do not shake hands, but the people routing them certainly do. That was the useful, rather human point underneath COSCO SHIPPING's presence at the ninth China International Import Expo in Shanghai: global logistics is a physical business built on relationships that have to survive different languages, markets,...

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 43

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading
Arbor Realty's Loan Mess Meets a Dividend Shutdown

Updated Category News Views 89

A dividend suspension lands differently when the loan book is already coughing up smoke. Arbor Realty Trust’s latest disclosed numbers are not the sort that investors can shrug off as one ugly quarter and forget by Friday. The company reported a third-quarter 2026 GAAP net loss of $85.4 million, suspended its quarterly cash dividend effective immediately, and described...

Continue Reading
Swell Partners' Awards Highlight Culture, Not Metrics

Updated Category News Views 41

Recognition Lands in a Crowded Talent Market Two shiny Stevie trophies do not pay payroll, but they can say something useful about a company trying to stand out in the noisy talent-services business. Swell Partners has been named 2026 Company of the Year in Business Services and has seen founder and CEO Cari Gatto receive Best Female CEO of the Year. For a private firm...

Continue Reading
Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 77

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 126

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading
Honda Prelude’s Hybrid Return Tests a Narrow Niche

Updated Category News Views 0

A low-slung coupe showing up in Newfoundland is not exactly a volume-sales thunderclap, and that is precisely why the 2027 Honda Prelude deserves a closer look. Steele Honda in St. John’s is presenting the hybrid two-door as a fresh choice for buyers who want something livelier than the usual practical commuter. For Honda, and for investors watching Honda Motor Co....

Continue Reading

Top 5 Most Recently Viewed Articles

Safety Socket LLC Wins Major Court Ruling Against Counterfeiters

Updated Category News Views 692

Safety Socket LLC Achieves Legal Victory Against Counterfeit Suppliers The jury in a federal court trial has ruled in favor of Safety Socket LLC, confirming that certain fasteners intended for military applications were counterfeit. This significant case, known as Safety Socket LLC v. Relli Technology, Inc., was adjudicated in the U.S. District Court for the Northern...

Continue Reading
Innovative Energy Project Completion in the Gulf of Mexico

Updated Category News Views 244

Completion of McDermott's EPCIC Project in Gulf of Mexico Recently, McDermott celebrated the successful conclusion of its engineering, procurement, construction, installation, and commissioning (EPCIC) project for Shell Offshore Inc., a subsidiary of Shell plc. This project, executed in the Gulf of Mexico, is pivotal in starting oil production at the Whale development....

Continue Reading
Hyperscale Data Plans Major Expansion for AI Infrastructure

Updated Category News Views 365

Significant Power Capacity Increase for Hyperscale Data Hyperscale Data, Inc. (AMEX: GPUS) has recently reported a promising advancement as its subsidiary, Alliance Cloud Services (ACS), has reached a preliminary agreement aimed at boosting the power capacity at its data center. This enhancement, intended to promote growth in artificial intelligence (AI) infrastructure,...

Continue Reading
Global Sewage Crisis Costs $4 Trillion Annually

Updated Category News Views 17

The Overlooked Menace of Sewage Pollution Folks, let me hit you with a harsh reality: while everyone’s chatting about plastic in the ocean or overfishing, there’s a silent disaster slipping under the radar. We’re talking sewage pollution—an issue so vast it's draining the global economy to the tune of $4 trillion each year. That’s what they’re yammering about...

Continue Reading
Inspire Medical Systems, Inc. Class Action Lawsuit Update

Updated Category News Views 231

Inspire Medical Systems, Inc. Investors Take Note The financial landscape for investors is anything but static, particularly for those involved with Inspire Medical Systems, Inc. This article serves as a reminder for investors about the ongoing class action lawsuit, including the critical lead plaintiff deadline. Investors should remain vigilant and informed regarding...

Continue Reading